Ann Lab Med.  2020 Sep;40(5):431-434. 10.3343/alm.2020.40.5.431.

Successful Desensitization by Post-Centrifugal Plasma Filtration in Two Highly Sensitized Heart and Lung Transplant Recipients

Affiliations
  • 1Department of Laboratory Medicine and Research, Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea
  • 2Department of Laboratory Medicine, Pusan National University Hospital, Busan, Korea
  • 3Department of Cardiovascular and Thoracic Surgery and Research, Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea
  • 4Department of Pulmonology and Critical Care Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea
  • 5Division of Cardiology, Department of Internal Medicine and Research, Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea


Figure

  • Fig. 1 Changes in DSAs with desensitization treatment. (A) A heart transplant recipient (Case 1, Table 1) with preformed DSAs and (B) a lung transplant recipient (Case 2, Table 1) who underwent desensitization before donor matching. Abbreviations: ATG, anti-thymocyte globulin; DSA, donor-specific antibody; IVIG, intravenous immunoglobulin; MFI, mean fluorescence intensity; PCPF, post-centrifugal plasma filtration; POD, postoperative day.


Reference

1. Al-Mohaissen MA, Virani SA. Allosensitization in heart transplantation: an overview. Can J Cardiol. 2014; 30:161–72.
Article
2. Li F, Atz ME, Reed EF. Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways. Curr Opin Immunol. 2009; 21:557–62.
Article
3. Colvin MM, Cook JL, Chang PP, Hsu DT, Kiernan MS, Kobashigawa JA, et al. Sensitization in heart transplantation: Emerging knowledge: A scientific statement from the American Heart Association. Circulation. 2019; 139:e553–78.
Article
4. Colvin MM, Cook JL, Chang P, Francis G, Hsu DT, Kiernan MS, et al. Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2015; 131:1608–39.
5. Park BG. Desensitization in HLA incompatible transplantation. Korean J Blood Transfus. 2019; 30:1–14.
Article
6. Jordan SC, Reinsmoen N, Lai CH, Vo A. Novel immunotherapeutic approaches to improve rates and outcomes of transplantation in sensitized renal allograft recipients. Discov Med. 2012; 13:235–45.
7. Patel J, Everly M, Chang D, Kittleson M, Reed E, Kobashigawa J. Reduction of alloantibodies via proteasome inhibition in cardiac transplantation. J Heart Lung Transplant. 2011; 30:1320–6.
8. Iyer HS, Jackson AM, Zachary AA, Montgomery RA. Transplanting the highly sensitized patient: trials and tribulations. Curr Opin Nephrol Hypertens. 2013; 22:681–8.
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr